We are live on ! Find out more
MC

Martin & Co Portfolio holdings

AUM $640M
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+23.57%
3 Year Est. Return
+67.79%
5 Year Est. Return
+76.4%
10 Year Est. Return
+289.06%
AUM
$587M
AUM Growth
+$4.72M
Cap. Flow
+$9.82M
Cap. Flow %
1.67%
Top 10 Hldgs %
44.73%
Holding
101
New
1
Increased
92
Reduced
5
Closed

Top Sells

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$2.45M
2
NVDA icon
NVIDIA
NVDA
+$111K
3
CENT icon
Central Garden & Pet Co
CENT
+$24.5K
4
TT icon
Trane Technologies
TT
+$7.22K
5
AMGN icon
Amgen
AMGN
+$356

Sector Composition

Rank Sector Weight
1 Financials 9.13%
2 Industrials 8.9%
3 Technology 8.26%
4 Healthcare 8.13%
5 Consumer Staples 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
101
Eli Lilly
LLY
$1.08T
$213K 0.04%
232

Similar funds

Martin & Co's Q1 2026 Portfolio in Review

As of Q1 2026, Martin & Co held 101 positions worth $587M, up 0.81% from $583M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 0.99%. Martin & Co opened 1 new position and made no exits, leaving the 101-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 9.1% of assets, down from 9.7% a quarter earlier, followed by Industrials and Technology.

  • Martin & Co's largest Q1 2026 buy was Viemed Healthcare: 273,001 shares worth $2.51M.
  • Martin & Co added most to iShares TIPS Bond ETF in Q1 2026, an estimated $2.15M increase.
  • Martin & Co's biggest Q1 2026 reduction was SLB Ltd, cutting an estimated $2.45M.
  • Martin & Co's ten largest holdings make up 45% of its $587M portfolio in Q1 2026.
  • Martin & Co opened 1 new position and closed 0 in Q1 2026.
  • Martin & Co's portfolio value rose 0.81% quarter-over-quarter to $587M.

Based on Martin & Co's 13F filing for Q1 2026, filed 14 May 2026.